Skip to main content
A Review of Mesenchymal Stem Cell Injections for Osteoarthritis
Marshall Journal of Medicine
  • Ammar Qureshi, Marshall University
  • Jill Goodwin, University of Arizona- College of Medicine Phoenix
  • Franklin D. Shuler, Marshall University
  • Timothy Wilson-Byrne, Marshall University Joan C. Edwards School of Medicine
  • John J. Jasko, Marshall University
  • Charles Giangarra, Marshall University Joan C. Edwards School of Medicine
Author Credentials
Charles Giangarra MD Jill Goodwin MD Franklin D. Shuler MD Timothy Wilson-Byrne MD John J. Jasko MD Ammar Qureshi MD

Mesenchymal stem cell (MSC) injections for osteoarthritis is reviewed.

Methods- PubMed search identifying articles in English from 2003-2018 that used intra- articular injection (IA), cartilage repair, cartilage regeneration, chondral injury, adipose stem cells, bone marrow stem cells, mesenchymal stem cells, or autologous stem cells.

Results – 388 patients receiving IA MSC injections are discussed with data obtained from 10 case reports or case series, 4 randomized clinical trials (RCT), 1 cohort study, and 3 case controlled therapeutic studies.

Conclusions – MSC injections may be an effective adjunct in the management of osteoarthritis and a variety of cartilage related pathologies.

Conflict(s) of Interest
References with DOI

1. Suri P, Morgenroth DC, Hunter DJ. Epidemiology of osteoarthritis and associated comorbidities. PM&R: The Journal of Injury, Function and Rehabilitation. 2012;4(5 Suppl):S10-19.

2. Wiesel S, Delahay J. Essentials of Orthopedic Surgery. New York: Springer Science and Business Media; 2010.

3. Dillon CF, Rasch EK, Gu Q Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis datafrom the Third National Health and Nutrition Examination Survey. 2006;33(11):2271-2279.

4. Granero-Molto F, Weis JA, Longobardi L, Spagnoli A. Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opinion on Biological Therapy. 2008;8(3):255-268.

5. Bobacz K. Pharmacologic treatment of hand-, knee- and hip-osteoarthritis. Wien Med Wochenschr. 2013;163(9-10):236-242.

6. Hochberg MC, Altman RD et al. American College of Rheumatology 2012 Recommendations for the Use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465-474.

7. Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. Journal of the American Academy of Orthopaedic Surgeons. 2013;21(9):571-576.

8. Steinert A. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther. 2007;9(3):213.

9. Anders S et al. A randomized controlled trial comparing autologous matrix-induced chondrogenesis (AMIC(R)) to microfracture: analysis of 1- and 2-year follow-up data of 2 centers. Open Orthop J. 2013; 7:133-143.

10. Abumaree M, Al Jumah M, Pace RA, Kalionis B. Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev Rep. 2012;8(2):375-392.

11. Nemeth K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine. 2009;15(1):42-49.

12. Maggini J, et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010;5(2):e9252.

13. Caplan AI Dennis JE. Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry. 2006;98(5):1076-1084.

14. Manferdini C. Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. Arthritis Rheum. 2013; 65(5):1271-1281.

15. McIlwraith C. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects. Arthroscopy. 2011;27(11):1552-1561.

16. Mokbel A. Homing and reparative effect of intra-articular injection of autologous mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet Disord. 2011;12:259.

17. Vilar J. Controlled, blinded force platform analysis of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs. BMC Vet Res. 2013;9:131.

18. Toghraie F. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit. Knee. 2011;18(2):71-75.

19. Gimble JM, et al. Adipose tissue as a stem cell source for musculoskeletal regeneration. Front Biosci. 2011;3:69-81.

20. Vinatier C, et al. Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther. 2009;4(4):318-329.

21. Toghraie F. Scaffold-free adipose-derived stem cells (ASCs) improve experimentally induced osteoarthritis in rabbits. Arch Iran Med. 2012;15(8):495-499.

22. Jedrzejas KS M, Czekaj P. Stem cell niches exposed to tobacco smoke. Przegl Lek. 2012;69(10):1063-1073.

23. Wakitani S, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage. 2002;10(3):199-206.

24. Schäffler A, Büchler C. Concise review: adipose tissue‐derived stromal cells—basic and clinical implications for novel cell‐based therapies. Stem cells. 2007;25(4):818-827.

25. Casteilla L, Planat-Benard V, Cousin B, Silvestre JS, Laharrague P, Charriere G, Carriere A, Penicaud L. Plasticicity of adipose tissue: a promising therapeutic avenue in the treatment of cardiovascular and blood diseases? Arch Mal. Coeur Vaiss. 2005;98(9):922-926.

26. Pak J. Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads. Pain Physician. 2012;15(1):75-85.

27. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheumatol. 2005;52(8):2521-2529.

28. Buckley CT, et al. Functional properties of cartilaginous tissues engineered from infrapatellar fat pad-derived mesenchymal stem cells. Journal of Biomechanics. 2010;43(5):920-926.

29. Qi GF Y, Yan W. Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Mol Biol Rep. 2012;39(5):5683-5689.

30. Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19(6):902-907.

31. ML, Karli DC, Rettig AC. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014;42(2):463-471.

32. Centeno C. Safety and Complications Reporting on the Re-Implantation of Culture expanded Mesenchymal Stem Cells Using Autologous Platelet Lysate Technique. Curr Stem Cell Res Ther.; 2010.

33. Centeno CJ, et al. Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther. 2010;6(4):368-378.

34. Centeno C. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11(3):343-353.

35. Davatchi F. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int JRheum Dis. 2011;14(2):211-215.

36. Emadedin M. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med. 2012;15(7):422-428.

37. Lee K. A novel, minimally-invasive technique of cartilage repair in the human knee using arthroscopic microfracture and injections of mesenchymal stem cells and hyaluronic acid—a prospective comparative study on safety and short-term efficacy. Ann Acad Med Singap. 2012;41(11):511-517.

38. Varma HS, Dadarya B, Vidyarthi A. The new avenues in the management of osteo-arthritis of knee–stem cells. J Indian Med Assoc. 2010;108(9):583-585.

39. Wong KL, Lee KBL, Tai BC, Law P, Lee EH, Hui JHP. Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up. Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 2013;29(12):2020-2028.

40. Orozco L. Treatment of knee osteoarthritis with autologous mesenchymal stemc: a pilot study. Transplantation. 2013;95(12):1535-1541.

41. Vangsness CT, Farr J, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am. 2014;96(2):90-98.

42. Pak J, Lee JH, Lee SH. A novel biological approach to treat chondromalacia patellae. PLoS One. 2013;8(5):e64569.

43. Pak J. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series. J Med Case Rep. 2011;5:296.

44. Koh Y. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy. 2013;29(4):748-755.

45. Kim Y. Clinical outcomes of mesenchymal stem cell injection with arthroscopic treatment in older patients with osteochondral lesions of the talus. Am J Sports Med. 2013;41(5):1090-1099.

46. Spasovski D, Spasovski V, Baščarević Z, et al. Intra-articular injection of autologous adipose-derived mesenchymal stem cells in the treatment of knee osteoarthritis. J Gene Med. 2018;20(1).

47. Saw K. Articular cartilage regeneration with autologous peripheral blood progenitor cells and hyaluronic acid after arthroscopic subchondral drilling: a report of 5 cases with histology. Arthroscopy. 2011;27(4):493-506.

48. Saw K. Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial. Arthroscopy. 2013;29(4):684-694.

49. Turajane T. Combination of intra-articular autologous activated peripheral blood stem cells with growth factor addition/ preservation and hyaluronic acid in conjunction with arthroscopic microdrilling mesenchymal cell\ stimulation Improves quality of life and regenerates articular cartilage in early osteoarthritic knee disease. JMed Assoc Thai. 2013;96(5):580-588.

50. Vega A, Martín-Ferrero MA, Del Canto F, et al. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015;99(8):1681.

51. Lee J. In vivo tracking of mesechymal stem cells using fluorescent nanoparticles in an osteochondral repair model. Mol Ther. 2012;20(7):1434-1442.

52. Moriguchi Y. Repair of meniscal lesions using a scaffold-free tissue-engineered construct derived from allogenic synovial MSCs in a miniature swine model. Biomaterials. 2013;34(9):2185-2193.

Citation Information
Ammar Qureshi, Jill Goodwin, Franklin D. Shuler, Timothy Wilson-Byrne, et al.. "A Review of Mesenchymal Stem Cell Injections for Osteoarthritis" p. 46
Available at: